Fig 1. Mutation distribution in endometrial cancers.

A. Percent coding and non-coding mutations in endometrial cancers. B. Distribution of coding mutations by endometrial cancer histology. C. Percent coding driver (CHASM) and pathogenic (VEST4) mutations out of total mutations in A in endometrial cancers. D. Distribution of nucleotide substitutions in coding endometrial mutations (blue) compared with coding mutations in other cancers (red). Significant p values between the two samples are shown (t-test: independent samples, unequal variance, two tails). E. Chromosomal re-arrangements in endometrial cancers. Data extracted using the CONNAN function on COSMIC.